Fungal Infections

Fungal infection can be both superficial and can also penetrate deep inside the body. They trigger the immune system causing inflammation or tissue damage. Both the topical treatment and drugs are used to treat these infections. This session deals with all those aspects related to fungal infections 

The global antifungal drugs market size was valued at USD 11.3 billion in 2017. Raising prevalence of fungal infections such as Aspergillosis and Candidiasis is the key factor propelling the market. Global Antifungal Drugs Market is predicted to rise from 13,719 USD million in 2016 to 17,718 USD million by 2023. The industry is anticipated to register a CAGR of 3.7%, during the forecast period of 2017 - 2023. 

Sub-Tracks

• Aspergillosis and Candidiasis
• Athlete’s foot
• Ringworm and Yeast infections
• Skin Fungal Infections
• Fungal Diseases in Soil
• Anti-Fungal therapies

Market Analysis: The future of the fungal infections market is characterized by a shift towards more sophisticated, targeted, and innovative solutions, going beyond a simple increase in drug sales. While the anti-fungal drug market is forecasted to grow from roughly $17 billion in 2025 to over $22 billion by 2030, a key, unique driver of this expansion is the growing threat of antifungal resistance, which is prompting a new wave of research and development. This has led to the emergence of novel drug classes, such as triterpenoids like ibrexafungerp, which offer new mechanisms of action to combat pathogens that have become resistant to existing treatments. Simultaneously, the market for fungal diagnostics is experiencing an even faster growth trajectory, with a projected CAGR of 9.5% to reach an estimated $4.9 billion by 2032. This is driven by a critical need for rapid and accurate identification of specific fungal species and their resistance profiles, enabling personalized and more effective treatment. A further and increasingly unique factor shaping the market is climate change, which is expanding the geographic range of pathogenic fungi like Coccidioides and increasing their virulence. This environmental factor, coupled with a growing population of immunocompromised individuals, is creating a "perfect storm" that is forcing a re-evaluation of public health strategies and driving demand for new and accessible therapies to address this evolving global threat. 

for more details: https://microbiology-infectiousdiseases.peersalleyconferences.com/tracks/fungal-infections